Generate a tailored SOP for Dr. Sravan Perla. Improve your application with a focused, well-structured draft.
Sravan Perla obtained an M.Sc. in Medical Biochemistry from JIPMER, Puducherry, India, and subsequently joined the Indian Institute of Science (IISc) in Bangalore. He completed his Ph.D. at the University of Toledo School of Medicine and New York Medical College in the USA, where he studied epigenetic regulation of the human Angiotensinogen gene. After earning his Ph.D., he moved to Yale School of Medicine to work with Anton Bennett, exploring signaling mechanisms of Protein Tyrosine Phosphatases and their regulation in congenital heart diseases. His current research aims to decode the PZR/Shp2/Irx3/Irx5/BMP10 signaling pathway to find therapeutic targets for treating cardiovascular diseases, particularly Noonan syndrome and related conditions. He is developing novel therapies for congenital heart defects and plans to focus on treating Hypertrophic Cardiomyopathy using recombinant human BMP10, a critical ligand in TGF-beta signaling associated with cardiovascular development. He is also involved in repurposing existing medicines for disease treatment and has promising early data on treating cardiomyopathy with low-dose dasatinib.
Administered via the Graduate School of Arts and Sciences (GSAS). GRE General is optional for PhD.